Reference
Fabiani C, et al. Efficacy and safety of adalimumab in Behcet's disease-related uveitis: a multicenter retrospective observational study. Clinical Rheumatology 36: 183-189, No. 1, Jan 2017. Available from: URL: http://doi.org/10.1007/s10067-016-3480-x - Italy
Rights and permissions
About this article
Cite this article
Adalimumab. Reactions Weekly 1643, 14 (2017). https://doi.org/10.1007/s40278-017-27487-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-017-27487-5